Pfizer has submitted research to the U.S Food and Drug Administration on the effectiveness of its COVID-19 vaccine in children but the shots may not be available until November. The company said Tuesday it provided health regulators with data from a recent study of its vaccine in children 5 to 11 years old.from IndiaTV World: Google News Feed https://ift.tt/3CWkWyU
No comments:
Post a Comment